Jingli Lü

department of pharmacy

H指数:23

被引数:1,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

All-Trans Retinoic Acid as a Predictor and Therapeutic Agent for Vascular Calcification

全反式维甲酸作为血管钙化的预测因子和治疗剂

IUBMB Life

IF3.2

2025-10-090

PRE

Interleukin-33 promotes lipolysis of adipocytes and protects male mice against obesity via activation of β-adrenergic receptor signaling

白介素-33通过激活β-肾上腺素能受体信号通路促进脂肪细胞脂解，并保护雄性小鼠免受肥胖影响。

International Journal of Obesity

IF3.8

2025-08-120

OAAI

Physiologically based pharmacokinetic modeling supports investigation of potential drug-drug interactions in the pre- and early post-hematopoietic stem cell transplantation stages

生理学基础的药代动力学建模支持在造血干细胞移植前及移植早期阶段对潜在药物-药物相互作用的调查

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-05-020

Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin

MICROBIOLOGY SPECTRUM

IF3.8

2025-01-070

OAAI

Interleukin-33: Expression, regulation and function in adipose tissues

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-12-010

PRE

IL-33 promotes pancreatic β-cell survival and insulin secretion under diabetogenic conditions through PPARγ

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2023-11-011

PRE

Obesity alters immunopathology in cancers and inflammatory diseases

OBESITY REVIEWS

IF7.4

2023-09-194

Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients

MICROBIOLOGY SPECTRUM

IF3.8

2023-02-146

OAAI

Interleukin-33: Metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-08-017

OAAI

A Prediction Model for Tacrolimus Daily Dose in Kidney Transplant Recipients With Machine Learning and Deep Learning Techniques

FRONTIERS IN MEDICINE

IF3

2022-05-2713

OAAI

Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells

调节性T细胞表观遗传重编程的代谢控制

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-0515

OAAI

Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2021-06-017

OAAI

Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations

来自广泛期小细胞肺癌患者的循环肿瘤DNA的基因组分析确定了潜在的可行改变

JOURNAL OF CANCER

IF3.2

2021-01-0110

OAAI

Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes

肥胖和2型糖尿病的脂肪组织驻留免疫细胞

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-05-22107

OAAI

Interleukin-33 prevents the development of autoimmune diabetes in NOD mice

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2019-05-0116

PREAI

Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model

基于共表达相似性的肺腺癌早期诊断标志物的鉴定及诊断模型的构建

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2018-07-2010

OAAI

Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer

CANCER RESEARCH

IF16.6

2018-04-01226

OAAI

Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2018-01-0725

OAAI

Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression

LIFE SCIENCES

IF5.1

2017-10-0168

PREAI

Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes

FRONTIERS IN IMMUNOLOGY

IF5.9

2017-09-2913

OAAI

Jingli Lü

个人简介

教育背景

工作经历

荣誉奖项

研究方向